Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Zydus Lifesciences Drug Patent Portfolio

Zydus Lifesciences's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Zydus Lifesciences News

India's struggle against evergreening: The year 2026 could put the drug patent system to the test - Business Standard

15 Mar, 2026

With the patent expiration of semaglutide, a surge in weight-loss opportunities emerges. Pharmaceutical companies make significant investments while a legal dispute remains unresolved.

07 Mar, 2026

Zydus's Initial GLP-1 Strategy: A Missed Chance or Wise Financial Oversight?

03 Mar, 2026

Zydus plans to introduce a semaglutide injection featuring a reusable pen device on the day the patent expires.

27 Feb, 2026

See More